Naltech - Due diligence report
A 360° intelligence report on Naltech: trust score, financial health, credit view, compliance, directors, growth and distress signals - gene…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Naltech — 360° Intelligence Report
Generated from MCA filings & public recordsNaltech is assessed as Low Risk with a Trust Score of 82/100. Naltech is an active public not for profit company incorporated in 1993, operating in the Travel and Hospitality sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 02 Jul 2026 from the latest processed filings. Naltech snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- Litigation present in 1 court forum(s).
- 1 active GST registration(s).
Director Intelligence
Stability score: 45/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ALEVOOR RAGHUPATHY UPADHYA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RISHINARADAMANGALAM VISWANATHAN KRISHNAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MADRAS RAMANATHAN SIVARAMAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RANJAN MOODITHAYA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHYAM CHETTY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ARUNAKAR MISHRA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 6 directors on the board.
- MADRAS RAMANATHAN SIVARAMAN has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
As per FY 2022 annual returnFull shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 65 · Distress 90Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
MCA Filings & Events Timeline
Latest 15 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Catalyst Clinical | U24239DL2004PTC125941 | Delhi, Delhi, India |
| Adiuvodiagnostics | U74120AP2015PTC097966 | Nellore, Andhra Pradesh, India |
| Zaint Health Care Private Limited | U73100TG2019PTC135714 | Medak, Telangana, India |
| Navoday Sciences Private Limited | U74999RJ2018PTC060465 | Girwa, Rajasthan, India |
| Aakaar Biotechnologies Private Limited | U73100UP2014PTC064460 | Kanpur, Uttar Pradesh, India |
| Pibco Limited | U23956DL1965PLC004350 | New Delhi, Delhi, India |
| Pharmadesk Solutions | U74140MH2011PTC215460 | Navi Mumbai, Maharashtra, India |
| Prosetta Biosciences | U51397KA2004PTC033501 | Mysore, Karnataka, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Naltech before audits and certifications: compliance score 81/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Naltech: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Naltech - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether Naltech pays its suppliers before you extend credit terms.
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Naltech - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Naltech an active company?
Naltech has MCA status “Active” with a compliance score of 81/100 (Low Risk).
Is Naltech financially healthy?
Naltech has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.
Should I do business with Naltech?
Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Naltech?
See the directors and ownership sections above for board and shareholding detail. 6 active director(s) are on record.
Does Naltech have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Naltech up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 81/100 (Low Risk).
Is it risky to lend to Naltech?
Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.